Zoetis Inc. (ZTS)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Ms. Kristin C. Peck
|
CEO & Director | 5.42M | 42.25k | 1971 |
|
Ms. Roxanne Lagano
|
Executive VP, General Counsel & Corporate Secretary | 1.44M | -- | 1965 |
|
Mr. Wetteny N. Joseph CPA
|
Special Advisor to the CEO | 1.8M | -- | 1972 |
|
Dr. Robert J. Polzer Ph.D.
|
Scientific Advisor | 1.45M | -- | 1969 |
|
Mr. Jamie Brannan
|
Executive VP & Chief Commercial Officer | 1.74M | -- | 1973 |
|
Mr. James K. Saccaro
|
Executive VP, CFO & COO | -- | -- | 1973 |
|
Mr. Keith Sarbaugh
|
Executive VP & Chief Digital and Technology Officer | -- | -- | 1979 |
|
Mr. Steven Frank
|
Vice President of Investor Relations | -- | -- | -- |
|
Ms. Julie A. Fuller
|
Executive VP, Chief Human Resources Officer & Global Operations | -- | -- | 1973 |
|
Mr. Abhay U. Nayak
|
Executive VP & President of U.S. Commercial Operations | -- | -- | 1988 |
Zoetis Inc.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 14,500
Description
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
Corporate Governance
Upcoming Events
October 30, 2026 at 12:00 AM UTC
Ex-Dividend Date
November 5, 2026 at 12:30 PM UTC
Zoetis Inc. Earnings Date
December 1, 2026 at 12:00 AM UTC
Dividend Date
Recent Events
May 28, 2026 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
